Ventricular Assist Device Market Size to Surpass USD 2.56 Billion by 2030, With 10.8% CAGR

According to Fortune Business Insights, The Global Ventricular Assist Device Market size is projected to reach USD 2.56 Billion by 2030, at a CAGR of 10.8% during the forecast period, 2023-2030

Pune, India, March 31, 2023 (GLOBE NEWSWIRE) -- The global Ventricular Assist Device Market size hit USD 1.15 billion in 2022. The market valuation is expected to grow from USD 1.25 billion in 2023 to USD 2.56 Billion by 2030 at a 10.8% CAGR during the forecast period.

Heart Failure (HF) prevalence has been rising noticeably all over the world. The prevalence of the disease is rising as a result of factors such as bad food and lifestyle changes, among others. According to a piece written by the AME Publishing Company, there were around 64.4 million cases of heart failure worldwide in 2020. 51% of the patients had severe heart failure, which represented the entire prevalence of heart failure. Ventricular Assist Devices (VAD) are a class of mechanical circulatory support devices that are implanted in heart failure patients with severe symptoms. VADs work by pumping blood from the heart's chambers to the body as a whole.

Key Industry Development:

February 2021: In the Early Feasibility Study, CARMAT has been permitted to employ a new version of its artificial heart.  

Get a Free Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/sample/ventricular-assist-device-market-106377

Report Scope

Report Coverage	Details
Forecast Period	2023 to 2030
Forecast Period 2023 to 2030 CAGR	10.8%
2030 Value Projection	USD 2.56 Billion
Base Year	2022
Market Size in 2022	USD 1.15 Billion
Historical Data for	2019 to 2021
No. of Pages	156

Key Takeaways

• Europe held the second-largest share in the market and is expected to grow at a significant CAGR owing to rising investments in the market coupled with newer product launches.

• The market size in North America stood at USD 0.59 billion in 2022

• The left ventricular assist device segment is set to lead the market by product.

• The key factors driving the market are the increasing prevalence of heart failure and the rising penetration of ventricular assist devices.

• Abbott and ABIOMED are the top players in the market.

Drivers and Restraints

Long Waiting Periods for Heart Transplants to Aid Growth 

The need for heart transplants has grown dramatically as the prevalence of heart failure rises globally. Yet, a global shortage crisis has emerged due to lack of sufficient heart donors to match the demand. In March 2022, the Health Resources & Services Administration reported that there were around 105,800 individuals on the waiting list for heart transplants. These factors drive the Ventricular Assist Device Market growth.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/ventricular-assist-device-market-106377

LVAD Segment to Experience Maximum Demand During 2023-2030

The market is divided into bi-ventricular assist devices, right ventricular assist devices, and Left Ventricular Assist Devices (LVAD). Due to patients around the world undergoing the most LVAD implantation procedures, LVAD held the largest market share in 2022.

Continuous Segment to Capture Maximum Share during the Forecast Period

The market is divided into the pulsatile flow and continuous flow based on the type of flow. In 2022, the continuous flow segment had a sizable market share due to its advantages. Benefits of continuous flow devices include low maintenance requirements, low noise levels, infrequent replacement needs, and few moving parts.

DT Application Segment to Generate Monumental Market Demand

The market is divided into Bridge to Transplant (BTT), Bridge to Candidacy (BTC), Destination Therapy (DT), and Bridge to Recovery (BTR) according to application. Due to variables such as increase in the frequency of heart failure in its terminal stages, Destination Treatment (DT) held the largest market share in 2022.

Hospitals and ASCs to Experience Robust Demand Through 2030

The market is divided into hospitals & ASCs and specialty clinics & others depending on the end user. Due to increase in hospital stays for patients having cardiac surgeries, such as device insertion or implant procedures, the hospitals & ASCs segment is anticipated to hold the majority of market share during the forecast period.

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• Recent industry developments include product launches, partnerships, mergers, and acquisitions.

Quick Buy: https://www.fortunebusinessinsights.com/checkout-page/106377

Regional Insights

North America to Dominate as Heart Failure Rates Increase

In 2022, the North America market had a value of USD 0.59 billion. The rising incidence of cardiovascular disorders in the area led to the domination of this regional market. Moreover, the adoption of these devices in the region has been fueled by an increase in collaborations and agreements among the major players that emphasize the growth of this market.

Due to increased market investments and the introduction of newer products, Europe, which had the second-largest Ventricular Assist Device Market share, is predicted to witness rapid growth.

Competitive Landscape

Strong VAD Sales Help Top Players Sustain Dominance

Among the leading industry participants, Abbott and ABIOMED held a sizeable global market share in 2022. Abbott held a substantial market share for ventricular assist devices globally. This is due to the result of the company's robust device sales. Also, the business places a high priority on strategic efforts with the intention of diversifying its product offers internationally.

List of the Companies Profiled:

• Berlin Heart (Germany)

• ABIOMED (U.S.)

• Abbott (U.S.)

• Jarvik Heart, Inc. (U.S.)

To Get This Report Customized, Visit: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/ventricular-assist-device-market-106377

Table Of Content

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

  • Market Trends

• Key Insights

  • Prevalence of Heart Failure, by Region, 2021

  • Number of Cardiac Surgeries, By Region/Country

  • New Product Launches, By Key Players

  • Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)

  • Impact of COVID-19 on the Market

• Global Ventricular Assist Device Market Analysis, Insights and Forecast, 2019-2030

  • Market Analysis, Insights and Forecast – By Product

    • Left Ventricular Assist Device

    • Right Ventricular Assist Device

    • Bi-Ventricular Assist Device

  • Market Analysis, Insights and Forecast – By Type of Flow

    • Pulsatile Flow

    • Continuous Flow

  • Market Analysis, Insights and Forecast – By Application

    • Bridge to Transplant (BTT)

    • Bridge to Candidacy (BTC)

    • Destination Therapy (DT)

    • Bridge to Recovery (BTR)

  • Market Analysis, Insights and Forecast – By End-user

    • Hospitals & ASCs

    • Specialty Clinics & Others

  • Market Analysis, Insights and Forecast – By Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

• North America Ventricular Assist Device Market Analysis, Insights and Forecast, 2019-2030

• Competitive Analysis

  • Global Market Share Analysis (2022)

  • Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))

    • Berlin Heart

    • ABIOMED

    • Abbott

    • Jarvik Heart, Inc.

    • Other Players

Toc Continued…!

Request a Complete TOC: https://www.fortunebusinessinsights.com/toc/ventricular-assist-device-market-106377

FAQ’s

What is the ventricular assist device market growth?

The global ventricular assist device market size is projected to grow from USD 1.25 billion in 2023 to USD 2.56 billion by 2030, exhibiting a CAGR of 10.8% during the forecast period.

How many ventricular assist devices are there?

The two basic types of VADs are a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD). If both types are used at the same time, they may be called a biventricular assist device (BIVAD)

Explore Our Trending Reports of Fortune Business Insight’s Healthcare Market:

ASEAN Contract Development and Manufacturing Organization Market Size, Share, Global Industry Trends and Industry Analysis

Medical Tape Market Size, Trends and Industry Analysis

Transrectal Ultrasound Market Share, Trends and Industry Analysis

Lung Cancer Screening Market Size and Industry Analysis

Vascular Plugs Market Growth, Trends, Size, Share and Industry Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth.

Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com